Literature DB >> 17214938

[Effect and mechanism of salvianolic acid B in attenuating elevated portal pressure in a rat model of portal hypertension induced by endothelin-1].

Yang Zhou1, Jie Gu, Lie-ming Xu.   

Abstract

OBJECTIVE: To investigate the effects of salvianolic acid B (SA-B) on portal hypertension induced by endothelin-1 in rats.
METHODS: Twenty-eight Sprague-Dawley rats were randomly divided into four groups: ET-1 group, ET-1+SA-B group, ET-1+ET(A)R blocker (BQ-123) group and ET-1+ET(B)R blocker (BQ-788) group. The rats of ET-1+SA-B group underwent intragastrical administration of salvianolic acid B for five days before ET-1 injection, while in three other groups' drinking water was given. In BQ-123 group or BQ-788 group, an intravenous injection of BQ-123 or BQ-788 via femoral vein was administered 30 minutes prior to ET-1 injection. Then changes of portal pressure, cervical artery pressure and heart rate were monitored continuously.
RESULTS: After ET-1 injection, the portal pressure of all rats in the ET-1 group increased significantly, while slightly in groups that pretreated with SA-B, BQ-123 or BQ-788.
CONCLUSION: SA-B can attenuate the elevated portal pressure induced by ET-1 with effect similar to ETR blocker.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17214938     DOI: 10.3736/jcim20070112

Source DB:  PubMed          Journal:  Zhong Xi Yi Jie He Xue Bao        ISSN: 1672-1977


  1 in total

1.  Salvianolic Acid B reducing portal hypertension depends on macrophages in isolated portal perfused rat livers with chronic hepatitis.

Authors:  Xin Zhao; Hongmei Jia; Shijun Yang; Yuetao Liu; Bo Deng; Xueyan Xu; Tao Zhang; Hang Zhou; Chengzhe Zu; He Yin; Ting Li; Yijun Song; Yueqi Wang; Pengtao Li; Zhongmei Zou; Dayong Cai
Journal:  Evid Based Complement Alternat Med       Date:  2012-10-16       Impact factor: 2.629

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.